MedTrace Logo

Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module

NCT03279939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2025-09-15

No results posted yet for this study

Summary

Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.

Conditions

  • Retinal Vascular
  • Normal Eyes

Interventions

DEVICE

OCT Angiography

OCT Angiography offers clinicians a non-invasive three-dimensional visualization of vasculature in the retina and choroid. The visualization of perfused vasculature in a three-dimensional layout, offers clinicians an aid in the identification of retinal and choroidal pathologies such as retinal ischemia, microaneurysms, retinal neovascularization and choroidal neovascular membranes.

DEVICE

Color Fundus Photography

Non-contact white light photography.

DEVICE

Fluorescein Angiography

An imaging procedure where dye is injected into a vein and images are taken of the back of the eye to visualize the perfusion of retinal vessels in two dimensional images.

DEVICE

Indocyaine Green Angiography

An imaging procedure where dye is injected into a vein and images are taken of the back of the eye to visualize the perfusion of choroidal vessels in two dimensional images.

Sponsors & Collaborators

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Principal Investigators

  • David Brown, MD · Retina Consultants Houston

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-23
Primary Completion
2018-01-12
Completion
2018-01-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03279939 on ClinicalTrials.gov